BIRC5 and neoplasm: Although most immunohistochemical studies show survivin predominantly located in the cytoplasm, in some tumours survivin may have a mainly nuclear cellular location by immunohistochemistry (Ito et al, 2000; Okada et al, 2001), and its expression in the nucleus may be associated with a more favourable outcome (Okada et al, 2001).